Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;32(1):113-115.
doi: 10.1111/iju.15587. Epub 2024 Oct 21.

Management of apalutamide-induced rash with focus on early peaks

Kohei Hashimoto  1 , Tetsuya Shindo  1 , Sachiyo Nishida  1 , Ko Kobayashi  1 , Toshiaki Tanaka  1 , Naoya Masumori  1
Affiliations

Management of apalutamide-induced rash with focus on early peaks

Kohei Hashimoto et al. Int J Urol. 2025 Jan.
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Chi KN, Agarwal N, Bjartell A, Chung BH, Pereira de Santana Gomes AJ, Given R, et al. Apalutamide for metastatic, castration‐sensitive prostate cancer. N Engl J Med. 2019;381:13–24.
    1. Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, et al. Apalutamide treatment and metastasis‐free survival in prostate cancer. N Engl J Med. 2018;378:1408–1418.
    1. Uemura H, Arai G, Uemura H, Suzuki H, Aoyama J, Hatayama T, et al. Safety and efficacy of apalutamide in Japanese patients with metastatic castration‐sensitive prostate cancer receiving androgen deprivation therapy: final report for the Japanese subpopulation analysis of the randomized, placebo‐controlled, phase III TITAN study. Int J Urol. 2022;29:533–540.
    1. Uemura H, Koroki Y, Iwaki Y, Imanaka K, Kambara T, Lopez‐Gitlitz A, et al. Skin rash following Administration of Apalutamide in Japanese patients with advanced prostate cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open‐label study. BMC Urol. 2020;20:139.
    1. Flynn CR, Liu SC, Byrne B, Ralph J, Paz G, Anwar S, et al. Apalutamide‐induced toxic epidermal necrolysis in a Caucasian patient with metastatic castration‐sensitive prostate cancer: a case report and review of the literature. Case Rep Oncol. 2023;16:652–661.

LinkOut - more resources